SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500660

INE159A01016

100.5174369

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GLAXO

44.12

41756.89

EPS(TTM)

Face Value()

Div & Yield %

55.87

2.19

Back

IndusInd Bank reports consolidated net loss of Rs 436.88 crore in the September 2025 quarter

Oct 18,2025

Net loss of IndusInd Bank reported to Rs 436.88 crore in the quarter ended September 2025 as against net profit of Rs 1331.29 crore during the previous quarter ended September 2024. Total Operating Income declined 8.49% to Rs 11608.63 crore in the quarter ended September 2025 as against Rs 12686.28 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Total Operating Income	11608.63	12686.28	-8
OPM %	42.76	54.66	-
PBDT	-583.85	1779.73	PL
PBT	-583.85	1779.73	PL
NP	-436.88	1331.29	PL

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)